Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accrual, andin, ASCO, aseptic, aseptically, authoritative, blinded, BMS, carrier, classical, clincial, conference, CRO, cytokine, devastating, differentiation, dissatisfaction, EMA, fashion, filled, filling, Formatech, frontline, fundraising, gauge, GB, GTR, guarantee, hematopoietic, Hemocyanin, impressive, intolerance, karnofsky, Keyhole, kidney, kill, KLH, lag, learning, leukemiasin, Limpet, lot, mutated, nonclinical, Novella, passed, PCR, pediatric, Pepin, perfect, pilot, polymerase, pontine, priming, progenitor, proportion, qualitative, reaction, reconsented, reconsider, recurrent, refractory, regime, reprocessed, reprocessing, resolution, RR, Sanofi, screening, Society, sterility, superfamily, surgery, surgically, TNF, uncovered, underwriter, underwriting, underwritten, virtually, vitro, vivo, voluntarily, worth
Removed:
acceleration, add, adult, Aduracil, applied, assertion, assign, assortment, assumption, AstraZeneca, attainment, Australia, AVAN, beta, biotech, burden, calcium, Camptosar, capecitabine, CAPM, CeaVac, challenging, childhood, cholerae, chorionic, collected, colorectal, constant, consummated, Contingency, court, culture, defining, delivered, diagnostic, discretionary, Division, earned, Eloxatin, emerging, Eniluracil, epithelial, Erbitux, estimable, estimating, excise, executed, fastest, focusing, forced, forma, funded, gonadotropin, head, Herceptin, ImClone, Immunex, implemented, incurrence, interfering, invalid, invalidity, investigational, irinotecan, irrespective, kind, lesser, Leucovorin, litigated, mandatory, mannose, MassDevelopment, Master, mechanism, mediate, merged, modified, mutatedVibrio, neck, Newbold, Northwest, orderly, oxaliplatin, pancreatic, path, pattern, paying, pertinent, poor, preventative, pro, Promissory, proving, recommended, recurring, reduction, regression, requirement, residual, resignation, resigned, retreatment, retrospective, route, routine, Ryan, schedule, selection, senior, separation, settled, simplified, sooner, suggesting, surviving, Titan, Tomudex, traditionally, Una, unaudited, undelivered, unregulated, vendor, VibrioVec, vice, weekly, Xeloda, yield
Filing tables
Filing exhibits
CLDX similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-151728, 333-117602 and 333-162423) and on Form S-3 (No. 333-165899) of Celldex Therapeutics, Inc. of our report dated March 8, 2012 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 8, 2012